Safety and Antiviral Study of ACH126, 433 (b-L-Fd4C) in Adults With Lamivudine-resistant Chronic Hepatitis B
Status:
Terminated
Trial end date:
2003-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to determine the safety and antiviral hepatitis B virus (HBV)
activity of ACH126, 433 in the treatment of adults with lamivudine-resistant chronic
hepatitis B.